Abstract: A system for resource targeted scheduling for a PON network.

Abstract: A system supporting the geographically dispersed remote optical line terminals.

Abstract: A system with OLTs having a meshed interconnection.

Abstract: A system with OLTs having a meshed interconnection.

Abstract: A system supporting the daisy chaining of remote optical line terminals.

Abstract: A system for resource targeted scheduling for a PON network.

Abstract: Methods and compositions for producing epidermal growth factor (EGF) in soybean seeds featuring the use of transgenic soybean seeds expressing a seed-specific codon optimized gene encoding of the hEGF protein. Using these methods, the production of hEGF is sufficient and the activity of the EGF protein is comparable to commercially available EGF. The present invention shows the feasibility of using soybean seeds as a biofactory to produce therapeutic agents for a delivery platform, e.g., in a soymilk delivery platform.

Abstract: Methods and compositions for producing epidermal growth factor (EGF) in soybean seeds featuring the use of transgenic soybean seeds expressing a seed-specific codon optimized gene encoding of the hEGF protein. Using these methods, the production of hEGF is sufficient and the activity of the EGF protein is comparable to commercially available EGF. The present invention shows the feasibility of using soybean seeds as a biofactory to produce therapeutic agents for a delivery platform, e.g., in a soymilk delivery platform.

Abstract: A database server that manages a database retrieves metadata that is stored, within the database, in association with a procedure that is stored in the database. Based on the metadata, a Web service definition is automatically constructed to describe the procedure as a Web service. The WSDL definition can be referenced to construct SOAP messages with the appropriate arguments and in the appropriate format which, when received, are converted to a suitable format for invoking execution of the procedure by the database server.

Abstract: This disclosure pertains to controllably bioabsorbable devices, particularly anchors for vascular closure plugs and to methods of use thereof.

Abstract: An implantable device includes at least one electrode comprising a conductive base and polyoxometalate anions disposed on or within the conductive base; and at least one conductor attached to the at least one electrode for conducting electrical energy to the at least one electrode.

Abstract: In one embodiment, a database server receives a request from a spreadsheet application to open a file with spreadsheet data. The spreadsheet data is stored in one or more relational tables in one or more relational databases that are managed by the database server. In response to the request, the database server generates the file, where generating the file comprises retrieving the spreadsheet data from an XML view that is defined by an XQuery query. When executed, the XQuery query returns the spreadsheet data in an XML spreadsheet format that is understood by the spreadsheet application. The database server provides the generated file with the spreadsheet data directly to the spreadsheet application, where the spreadsheet data as retrieved from the XML view is formatted according to the XML spreadsheet format.

Abstract: In embodiments, a stent includes a copolymer having a modulus of about 10 MPa or less and exhibiting hydrolytic degradation substantially by surface erosion. For example, the copolymer can include elastic segments formed of trimethyl carbonate polymer or copolymer, and rigid segments formed of a lactide, glycolide, ?-caprolactone polymer or copolymer.

Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.

Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.

Abstract: A computing device having partitions, and a method of communicating between partitions, are disclosed wherein at least one partition comprises: at least one register substantially always accessible to other partitions and capable of defining an address area; at least one address area that may be accessible to other partitions and is capable of being defined by the at least one register; and address areas other than the at least one accessible address area that are not accessible to other partitions. A method of processing interrupts comprising receiving an interrupt, assessing the origin of the interrupt, accepting, rejecting, or further assessing the interrupt, depending on its origin, when further assessing the interrupt, accepting or rejecting the interrupt depending on its contents, and forwarding accepted interrupts but not rejected interrupts to a target processor, and a device carrying out that method are also disclosed.

Abstract: In one aspect, the present invention provides composite coatings for implantable or insertable medical devices. These composite coatings comprise (a) an inorganic portion and (b) a polymeric portion that comprises a poly(vinyl pyrrolidone) (PVP) block.

Abstract: In accordance with an aspect of the invention, implantable or insertable medical devices are provided that comprise (a) a substrate and (b) a porous layer comprising close packed spherical pores disposed over the substrate. The porous layer may also comprise a therapeutic agent. In another aspect, the present invention provides methods of forming implantable or insertable medical devices. These methods comprise forming a predecessor structure that comprises (i) a substrate over which is disposed (ii) an assembly of microspheres. This assembly of microspheres is then used as a template for the formation of a porous layer, which may be subsequently loaded with a therapeutic agent.

Abstract: Bioerodible endoprostheses and methods of making the endoprostheses are disclosed. In some embodiments, an endoprosthesis includes a member including a bioerodible material, and an antioxidant carried by the member. Examples of antioxidants include phenols.

Abstract: A therapeutic agent delivery device and method for eluting a therapeutic agent to a target location are disclosed. The therapeutic agent delivery device may comprise a first conductive element, a second conductive element, and an electrochemical layer including a neurotoxin located between the first conductive element and the second conductive element. The first conductive element and the second conductive element are adapted to be connected to a voltage source. When the first conductive element and the second conductive element are connected to the voltage source, an electrochemical reaction occurs causing the neurotoxin to release from the electroactive layer and elute to a target location.